Rocket One Inc. RKTO

Q3 FY2024 · ended Sep 30, 2024 · Revenue $0 · Filed Nov 12, 2025

Rocket One Inc. (RKTO) files with the SEC under industry code 2834, Pharmaceutical Preparations.

Revenue
$0
Net income
$-3.83M
-74.3% vs year-ago quarter
Operating cash flow
$-2.97M
-25.1% vs year-ago quarter
Free cash flow
—
EPS
$-0.19
-11.8% vs year-ago quarter
Dividend per share
None
Shares outstanding
24.90M
+87.8% vs year-ago quarter
Net cash
$6.24M
Q4 FY2025
Operating margin
—

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RKTO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Hoboken, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1711786
Former names
Hoth Therapeutics, Inc. (until May 27, 2026)

Other Pharmaceutical Preparations companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Operating income
-$3.8M
-$2.6M
-$2.6M
-$4.1M
-$2.2M
Net income
-$3.8M
-$2.7M
-$2.7M
-$4.1M
-$2.2M
Diluted EPS
-$0.19
-$0.17
-$0.17
-$0.30
-$0.17
Operating cash flow
-$3.0M
-$3.1M
-$2.2M
-$2.5M
-$2.4M
Total assets
$9.6M
$5.6M
$7.6M
$9.2M
$10.1M
Total liabilities
$1.4M
$1.4M
$1.5M
$1.0M
$364,630
Stockholders' equity
$8.2M
$4.2M
$6.2M
$8.2M
$9.7M
Cash and investments
$7.9M
$4.0M
$6.2M
$7.8M
$9.0M
Total debt
—
—
$5,678
$13,599
$21,326

Recent SEC filings

Recent SEC filings
Form Description Filed Period
ARS Annual report to shareholders Oct 23, 2026 Dec 31, 2025
8-K Current report
Other events
Sep 25, 2026 Sep 22, 2026
8-K Current report
Other events
Sep 22, 2026 Sep 22, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Listing notice, Other events
Aug 11, 2026 Aug 6, 2026
8-K Current report
Other events
Jul 31, 2026 Jul 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.